UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of infectious diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 8, pp. 1279 - 1287
PATHOGENESIS AND HOST RESPONSE | pneumococcus | homing receptor | PCV | pneumonia | PPV | mucosal immune response | pneumococcal polysaccharide vaccine | lymphocyte homing | pneumococcal conjugate vaccine | Streptococcus pneumoniae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Pneumonia, Pneumococcal - immunology | Humans | Middle Aged | Vaccination | Immunity, Mucosal | Male | Polysaccharides - immunology | Respiratory System - cytology | Streptococcus pneumoniae - immunology | Young Adult | Vaccines, Conjugate - immunology | L-Selectin - immunology | Pneumococcal Vaccines - immunology | Adult | Antibodies, Bacterial - immunology | Female | Pneumonia, Pneumococcal - prevention & control | Aged | Respiratory System - immunology | Plasma Cells - immunology | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
European journal of epidemiology, ISSN 0393-2990, 1/2004, Volume 19, Issue 4, pp. 353 - 363
Pneumonia | Disease models | Pneumococcal pneumonia | Vaccination | Chronic diseases | Clinical trials | Disease risk | Experimentation | Infectious Diseases | Pneumococcal vaccine | Older adults | Medicine & Public Health | Oncology | Public Health/Gesundheitswesen | Cardiology | Epidemiology | Elderly | High-risk | Polysaccharide pneumococcal vaccine (PPV) | Vaccine efficacy (VE) | Meta-analysis | Life Sciences & Biomedicine | Public, Environmental & Occupational Health | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | Miscellaneous | Medical sciences | Confidence Intervals | Risk Assessment | Humans | Pneumococcal Infections - prevention & control | Pneumonia, Pneumococcal - prevention & control | Aged | Odds Ratio | Pneumococcal Vaccines | Randomized Controlled Trials as Topic | Vaccines | Older people | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 30, pp. 4763 - 4770
Allergy and Immunology | 7vCRM | Immunogenicity | PPV | Vaccine | Aged | Pneumococcus | B cell memory | ELISpot | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Microbiology | Applied microbiology | Biological and medical sciences | Bacteriology | Antibody Specificity | Age Factors | Immunoglobulin A - biosynthesis | Humans | Immunoglobulin M - analysis | Middle Aged | Vaccination | Male | Antibodies, Bacterial - analysis | Immunoglobulin G - biosynthesis | Female | Vaccines, Conjugate | Immunoglobulin G - analysis | Pneumococcal Vaccines - therapeutic use | Polysaccharides, Bacterial - immunology | Heptavalent Pneumococcal Conjugate Vaccine | Immunoglobulins - analysis | B-Lymphocytes - immunology | Sex Factors | Pneumococcal Vaccines - immunology | Immunologic Memory | Kinetics | Immunoglobulin A - analysis | Immunoglobulin M - biosynthesis | Plasma Cells - immunology | Polysaccharides | Vaccines | Pneumonia | Older people | Immune system | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 02/2019, Volume 37, Issue 10, pp. 1350 - 1355
Pneumococcal | IgA | PPV | IgG | Pneumovax | Normal | IgM | Medical research | Polysaccharides | Immunoglobulin G | Vaccination | Immunodeficiency | Medicine, Experimental | Adults | Immunoglobulin A | Health aspects | Immunoglobulin M | Immunoglobulins | Capsular polysaccharides | IgG antibody | Infections | Vaccines | Patients | Biological variation | Isotypes | Population | Age | Binding sites | Volunteers | Index Medicus
Journal Article
Human vaccines & immunotherapeutics, ISSN 2164-5515, 12/2014, Volume 10, Issue 12, pp. 3700 - 3710
OPA, opsonophagocytic activity | PPV, pneumococcal polysaccharide vaccine | PPV23, 23-valent pneumococcal polysaccharide vaccine | pneumococcal disease | invasive pneumococcal disease | ELISA, enzyme-linked immunosorbent assay | GMT, geometric mean titer | EACS, European AIDS Clinical Society | cART, combination antiretroviral therapy | immunodeficiency | IPD, invasive pneumococcal disease | ART, antiretroviral therapy | pneumococcal conjugate vaccine | TLR, toll-like receptor | PCV13, 13-valent pneumococcal conjugate vaccine | PCV7, 7-valent pneumococcal conjugate vccine | ACIP, Advisory Committee on Immunization Practices | AIDS | NA, not available | PVL, plasma HIV RNA load | immunogenicity | Streptococcus pneumoniae | DHHS, Department of Health and Human Services | pneumococcal polysaccharide vaccine | PCV, pneumococcal conjugate vaccine | Pneumococcal conjugate vaccine | Immunogenicity | Pneumococcal polysaccharide vaccine | Immunodeficiency | Invasive pneumococcal disease | Pneumococcal disease | Immunology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Vaccines, Conjugate - immunology | Virus Replication | Humans | Vaccination | Pneumococcal Vaccines - immunology | Adult | HIV Infections - drug therapy | CD4 Lymphocyte Count | Drug Therapy, Combination | Practice Guidelines as Topic | Index Medicus
Journal Article
Human vaccines & immunotherapeutics, ISSN 2164-5515, 12/2014, Volume 10, Issue 12, pp. 3688 - 3699
vaccines | IPDs, invasive pneumococcal diseases | immunity | PPS, pneumococcal polysaccharides | T cells | WCV, whole cell vaccine | MHC, major histocompatibility complex | PcpA, pneumococcal choline-binding protein A | Streptococcus pneumoniae | NP, nasopharynx | OPAs, opsonophagocytic antibodies | colonization | PPVs, pneumococcal polysaccharide vaccines | Vaccines | Immunity | Colonization | Immunology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | CD4-Positive T-Lymphocytes - immunology | Vaccines, Conjugate - immunology | Streptococcus pneumoniae - classification | Animals | Humans | Serogroup | Pneumococcal Vaccines - immunology | Th17 Cells - immunology | Infant | Mice | Nasopharynx - microbiology | Streptococcus pneumoniae - immunology | Index Medicus
Journal Article
Pneumonia, ISSN 2200-6133, 2017, Volume 9, Issue 1, pp. 20 - 20
Journal Article
Journal of medical microbiology, ISSN 0022-2615, 01/2009, Volume 58, Issue 1, pp. 101 - 104
ACIP, Advisory Committee on Immunization Practices | PCV7, heptavalent conjugate vaccine | PPV, 23-valent polysaccharide vaccine | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Infectious diseases | Bacterial diseases | Human bacterial diseases | Applied microbiology | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacteriology | Humans | Middle Aged | Vaccination | Male | Streptococcus pneumoniae - immunology | Pneumococcal Infections - epidemiology | Vaccines, Conjugate - immunology | Hospitals | Time Factors | Singapore - epidemiology | Adolescent | Aged, 80 and over | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Adult | Female | Aged | Index Medicus
Journal Article
BMC health services research, ISSN 1472-6963, 2012, Volume 12, Issue 1, pp. 313 - 313
Demand | Public relations | Vaccination program | Pneumococcal polysaccharide vaccine (PPV) | Price elasticity | Subsidy | Elderly | Life Sciences & Biomedicine | Health Care Sciences & Services | Science & Technology | Pneumococcal Vaccines - economics | Financing, Government - economics | Health Services Needs and Demand | Humans | Japan | Immunization Programs | Pneumonia, Pneumococcal - prevention & control | Surveys and Questionnaires | Aged | Models, Statistical | Pneumococcal Vaccines - supply & distribution | Surveys | Subsidies | Supply and demand | Elasticity (Economics) | Pneumococcal vaccine | Vaccination | Studies | Immunization | Pneumonia | Vaccines | Influenza | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. 597 - 606.e4
Allergy and Immunology | Recurrence | Humans | Middle Aged | Child, Preschool | Infant | Male | Antibiotic Prophylaxis | Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors | Young Adult | Immunoglobulins, Intravenous/therapeutic use | Enzyme Inhibitors/therapeutic use | Lymphoproliferative Disorders/genetics | Adult | Female | Surveys and Questionnaires | Child | Respiratory Tract Infections/genetics | Mutation/genetics | Hematopoietic Stem Cell Transplantation | International Cooperation | Herpesviridae Infections/genetics | Animals | Adolescent | Survival Analysis | Mice | Immunologic Deficiency Syndromes/genetics | Cohort Studies | Activated phosphoinositide 3-kinase δ syndrome | hematopoietic stem cell transplantation | phosphoinositide 3-kinase δ | immunodeficiency | phosphoinositide 3-kinase inhibitor | PIK3CD gene | bronchiectasis | p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Class I Phosphatidylinositol 3-Kinases - genetics | Herpesviridae Infections - mortality | Respiratory Tract Infections - genetics | Lymphoproliferative Disorders - therapy | Respiratory Tract Infections - mortality | Respiratory Tract Infections - therapy | Immunologic Deficiency Syndromes - mortality | Herpesviridae Infections - genetics | Immunologic Deficiency Syndromes - therapy | Lymphoproliferative Disorders - genetics | Mutation - genetics | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Lymphoproliferative Disorders - mortality | Herpesviridae Infections - therapy | Immunoglobulins, Intravenous - therapeutic use | Immunologic Deficiency Syndromes - genetics | Index Medicus | Abridged Index Medicus | Immune Deficiencies, Infection, and Systemic Immune Disorders | HSCT, Hematopoietic stem cell transplantation | BALF, Bronchoalveolar lavage fluid | CT, Computed tomography | APDS, Activated phosphoinositide-3 kinase δ syndrome | GOF, Gain of function | PI3K, Phosphoinositide 3-kinase | HSV, Herpes simplex virus | CMV, Cytomegalovirus | OR, Odds ratio | PPV, Pneumococcal polysaccharide vaccine | CNS, Central nervous system
Journal Article
Drugs & aging, ISSN 1170-229X, 2004, Volume 21, Issue 13, pp. 851 - 864
Beta lactams, therapeutic use | Pneumonia, treatment | Azithromycin, therapeutic use | Macrolides, therapeutic use | Pneumococcal vaccine conjugate PPV 23, therapeutic | Elderly | Antibacterial vaccines, therapeutic use | Protein 30S ribosomal subunit inhibitors, therapeu | Research and development | Community acquired pneumonia, treatment | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Community-Acquired Infections - diagnosis | Streptococcus pneumoniae - drug effects